Respiratory News and Research

RSS
Dramatic videos of OSA patients increase CPAP usage

Dramatic videos of OSA patients increase CPAP usage

International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

Viewpoints: New insurers suggest health law success; slow response on Ebola

Viewpoints: New insurers suggest health law success; slow response on Ebola

More reliable cardiorespiratory fitness data can be obtained using lean mass proportional measures

More reliable cardiorespiratory fitness data can be obtained using lean mass proportional measures

UTHealth researchers awarded $1.3 million grant to study asthma risk in Texas health care workers

UTHealth researchers awarded $1.3 million grant to study asthma risk in Texas health care workers

NIH, CSU scientists provide evidence that supports camels as primary carrier of MERS-CoV

NIH, CSU scientists provide evidence that supports camels as primary carrier of MERS-CoV

Screening and treating OSA patients prior to surgery reduce risk of cardiovascular complications

Screening and treating OSA patients prior to surgery reduce risk of cardiovascular complications

Tissue-level model of human airway musculature could pave way for patient-specific asthma treatments

Tissue-level model of human airway musculature could pave way for patient-specific asthma treatments

Desaturation 'area under the curve' may help in monitoring patient safety during procedures

Desaturation 'area under the curve' may help in monitoring patient safety during procedures

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Pneumonia in COPD patients has distinct clinical features

Pneumonia in COPD patients has distinct clinical features

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

Curie-Cancer, Inventiva launch Epicure project that aims to develop epigenetic targets for cancer

Curie-Cancer, Inventiva launch Epicure project that aims to develop epigenetic targets for cancer

Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Zebrafish may hold key to unlocking a leading cause of respiratory diseases

Zebrafish may hold key to unlocking a leading cause of respiratory diseases

Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

NSF, NIH, USDA receive more than $12 million in new EEID grants

NSF, NIH, USDA receive more than $12 million in new EEID grants

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.